Our Magazine
Brussels Morning Online Newspaper
Tuesday, April 20, 2021
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Online Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Online Newspaper
No Result
View All Result
Home EU Institutions Commission

Most EU citizens to be vaccinated by July says EC report

Nikola Kiš by Nikola Kiš
7 April 2021
in Commission
Most EU citizens to be vaccinated by July says EC report
Share on FacebookShare on Twitter

Brussels (Brussels Morning) Most EU citizens could be vaccinated by July according to a document released by the European Commission, Bloomberg reported on Tuesday.

The EC assumption is based on citizens accepting the vaccine developed by British-Swedish AstraZeneca pharmaceuticals.

The Commission notes that eight EU member states should have enough vaccines to inoculate more than 50% of their citizens by July, according to current confirmed vaccine orders.

These include Malta (93.1%), Denmark (79.9%), the Netherlands (64.6%), Germany (61%), France (58.2%), Spain (57.4%), Italy (57.1%) and Austria (51.3%).

EC optimism

The EC document claims that the bloc could achieve vaccination goals sooner than expected. The Commission previously noted it hoped to vaccinate 70% of the bloc’s adult population by the end of the summer.

However, depending on the demographics of EU member states, 70% of the adult population corresponds to between 55% and 60% of total population.

The document shows Brussels is becoming increasingly confident that the bloc’s vaccination campaign will get on track after the faltering start that was marked by contradictory messages, delays and political bickering.

EMA head at odds with own agency

Nonetheless, mixed messages about the AstraZeneca vaccine could jeopardise these latest projection given that Marco Cavaleri, head of vaccines at the European Medicines Agency (EMA), suggested on Tuesday that there could be a causal link between the shot and blood clots.

Later in the day, the EMA reported that no causal link between the vaccine and blood clots has been found, while adding, according to the Guardian, that  it is still investigating. 

Claims that the vaccine causes blood clots led some EU member states to suspend its use last month, while some countries restricted its use to specific age groups.

The EC expects the EU will receive some 355 million doses of vaccines between April and June. The total will comprise 55 million single-shot vaccines developed by US Johnson & Johnson pharmaceuticals and 300 million two-shot vaccines developed by AstraZeneca, BioNTech-Pfizer and Moderna.

Subscribe to Our Newsletter

Tags: Main-Slider
Nikola Kiš

Nikola Kiš

Nikola is Brussels Morning political affairs reporter, covering Germany, France, and Italy. Based in Zagreb, he is a translator with 18 years of experience reporting on political and business affairs.

Latest post

French astronaut Pesquet prepares for second ISS trip

French astronaut Pesquet prepares for second ISS trip

4 mins ago
Iran names fugitive citizen suspected of Natanz attack

Iran names fugitive citizen suspected of Natanz attack

6 hours ago

Most Read

  • A very Georgian provokatsiya

    A very Georgian provokatsiya

    0 shares
    Share 0 Tweet 0
  • EC to investigate €1bn worth of missing lumber in Croatian forests

    0 shares
    Share 0 Tweet 0
  • Salmond’s strategic masterstroke

    0 shares
    Share 0 Tweet 0
  • The explorer of non-places: interview with one of the world’s most intrepid travellers

    0 shares
    Share 0 Tweet 0
  • Seeking climate consensus amidst Sino-American rivalry

    0 shares
    Share 0 Tweet 0

Subscribe
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT